Clinical Trials Browser

Phase 1/2 × dacomitinib × Head & Neck × Clear all

NCT01116843 2015-07-10

Study to Assess Biomarkers in Patients With Resectable Oral Cavity Cancer Randomized to Receive Preoperative Treatment

Phase 1/2 Completed

Mouth Neoplasms